ACB Cardiac Marker May Receive Same Reimbursement Rate As BNP – Root

A modified albumin point-of-care test for ruling out heart attacks likely will receive similar reimbursement to the $47 rate for B-type natriuretic peptide tests, according to Charles Root, president of consulting firm MCF Compliance